Leptin reduces ovariectomy-induced bone loss in rats

Area of Science:

• Endocrinology
• Bone Biology
• Metabolic Research

Background:

• Obesity and fat body mass are linked to increased bone mineral density, offering protection against osteoporosis.
• Hormonal and mechanical factors partially explain the relationship between fat mass and bone mineral density.
• Serum leptin levels correlate strongly with fat body mass.

Purpose of the Study:

• To investigate the effects of leptin administration on ovariectomy-induced bone loss in rats.
• To compare leptin's efficacy with estrogen therapy in preventing bone loss.
• To explore the role of leptin in modulating bone remodeling pathways.

Main Methods:

• Ovariectomy-induced bone loss model in rats.
• Administration of leptin and estrogen therapy.
• Analysis of trabecular bone loss, bone architecture, and periosteal bone formation.
• In vitro studies on human marrow stromal cells assessing osteoprotegerin (OPG) and RANK ligand (RANKL) expression.

Main Results:

• Leptin effectively reduced trabecular bone loss, improved bone architecture, and modulated periosteal bone formation.
• Combined leptin and estrogen therapy showed a greater decrease in bone turnover than estrogen alone.
• Leptin increased OPG mRNA and protein levels while decreasing RANKL mRNA levels in vitro.
• Leptin therapy demonstrated a significant effect in preventing ovariectomy-induced bone loss.

Conclusions:

• Leptin therapy is effective in preventing ovariectomy-induced bone loss in rats.
• Leptin may modulate bone remodeling favorably, promoting better bone balance.
• The osteoprotegerin/RANK ligand pathway is a potential mediator of leptin's bone-protective effects.